| Issuer | % of Class | Filed |
|---|---|---|
|
Amneal Pharmaceuticals, Inc.
13D/A
Amendment 5
AMRX · 03168L105
|
5.4% |
3/26/2026
Event 12/31/2025
|
|
Amneal Pharmaceuticals, Inc.
13D/A
Amendment 4
AMRX · 03168L105
|
7.6% |
10/6/2025
Event 10/3/2025
|
|
Amneal Pharmaceuticals, Inc.
13D/A
Amendment 3
AMRX · 03168L105
|
7.7% |
1/23/2025
Event 11/13/2024
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.